D

Dong-A ST Co Ltd
KRX:170900

Watchlist Manager
Dong-A ST Co Ltd
KRX:170900
Watchlist
Price: 61 700 KRW -2.99% Market Closed
Market Cap: 553.9B KRW
Have any thoughts about
Dong-A ST Co Ltd?
Write Note

Relative Value

The Relative Value of one Dong-A ST Co Ltd stock under the Base Case scenario is 101 053.99 KRW. Compared to the current market price of 61 700 KRW, Dong-A ST Co Ltd is Undervalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
101 053.99 KRW
Undervaluation 39%
Relative Value
Price
D
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
39
vs Industry
72
Median 3Y
0.8
Median 5Y
0.9
Industry
2.5
Forward
0.8
vs History
vs Industry
8
Median 3Y
37.3
Median 5Y
23.3
Industry
21.9
Forward
19.5
vs History
vs Industry
2
Median 3Y
10
Median 5Y
11.6
Industry
16.5
vs History
38
vs Industry
31
Median 3Y
5.5
Median 5Y
4.5
Industry
23.6
vs History
20
vs Industry
64
Median 3Y
0.8
Median 5Y
0.9
Industry
2.1
vs History
39
vs Industry
78
Median 3Y
0.7
Median 5Y
0.8
Industry
2.6
Forward
0.6
vs History
41
vs Industry
76
Median 3Y
1.5
Median 5Y
1.6
Industry
5.2
vs History
4
vs Industry
13
Median 3Y
13.2
Median 5Y
12.7
Industry
13.3
Forward
7.2
vs History
vs Industry
10
Median 3Y
28.3
Median 5Y
16.4
Industry
16.6
Forward
13.4
vs History
vs Industry
2
Median 3Y
8.6
Median 5Y
10.4
Industry
15.6
vs History
vs Industry
Median 3Y
-11.2
Median 5Y
-9.8
Industry
19.1
vs History
47
vs Industry
74
Median 3Y
0.5
Median 5Y
0.6
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Dong-A ST Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Dong-A ST Co Ltd
KRX:170900
530.5B KRW 0.8 -79.4 42.6 -23.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
KR
D
Dong-A ST Co Ltd
KRX:170900
Average P/E: 32.4
Negative Multiple: -79.4
334%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top